Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000587505 | SCV000698074 | likely benign | not specified | 2019-08-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001432258 | SCV001635023 | likely benign | RASopathy | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002448824 | SCV002611481 | likely benign | Cardiovascular phenotype | 2019-05-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002491168 | SCV002796168 | likely benign | Noonan syndrome 1; Juvenile myelomonocytic leukemia; Metachondromatosis; LEOPARD syndrome 1 | 2021-11-29 | criteria provided, single submitter | clinical testing |